PF-3450074 is primarily used in pharmaceutical research as a potent and selective inhibitor of certain kinases, which are enzymes that play a critical role in cell signaling and regulation. Its application is focused on studying the mechanisms of diseases where these kinases are implicated, such as cancer, inflammatory disorders, and autoimmune conditions. Researchers utilize it to understand the pathways involved in these diseases and to explore potential therapeutic strategies. Additionally, it serves as a valuable tool in preclinical studies to assess the efficacy and safety of targeting specific kinases for drug development. Its role in advancing the understanding of cellular processes and its potential in creating targeted therapies make it a significant compound in biomedical research.